Colorectal cancer starts in the colon or the ... indicated Shield test may miss one in 10 people who have precancerous lesions and one in 1,000 people with cancerous lesions.

Christopher Burge is one of a growing number of young adults diagnosed with the disease, and hopes to spread awareness about the early signs.

The FDA has approved the first artificial intelligence-powered device that can be used to help identify colorectal lesions during the millions of colonoscopies carried out each year in the US.

Moreover, the differential diagnoses for a lesion by NBI are the same as those obtained by MCE. These results suggest that NBI can replace MCE as a diagnostic tool for assessing colorectal neoplasms.

and non-AI-assisted group (7.94), and 4.2% of participants in the AI group had a family history of colon cancer compared with 3.9% of those in the unassisted group. The most common benign lesions ...

Early detection of such lesions has been shown to reduce death rates from colorectal cancer, which kills about 50,000 people per year in the United States. The new technique, known as photometric ...

Colorectal cancer is one of the most common types of cancer, but with early detection and treatment, prognosis is generally pretty good. Regular screenings as well as understanding the signs and ...

We examined 107 specimens obtained from 98 patients who underwent endoscopic mucosal resection or endoscopic submucosal dissection of one or more colorectal lesions. The patients were treated at ...